Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Jul. 23, 2019 | Jun. 30, 2019 | |
Document And Entity Information | |||
Entity Registrant Name | WORLD HEALTH ENERGY HOLDINGS, INC. | ||
Entity Central Index Key | 0000943535 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2017 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filer | No | ||
Entity's Reporting Status Current | No | ||
Entity Interactive Data Current | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business Flag | true | ||
Entity Emerging Growth Company | false | ||
Entity Ex Transition Period | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 2,452,663 | ||
Entity Common Stock, Shares Outstanding | 89,789,407,996 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2017 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
CURRENT ASSETS | ||
Deposits | $ 3,000 | $ 3,000 |
Receivable from third party | 592 | |
Total current assets | 3,592 | 3,000 |
Total Assets | 3,592 | 3,000 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities | 88,298 | 89,039 |
Due related parties | 794,076 | 725,067 |
Related party convertible note payable | 21,474 | 21,474 |
Total current liabilities | 903,848 | 835,580 |
Commitments and Contingencies (note 12) | ||
DEFICIENCY IN STOCKHOLDERS' EQUITY | ||
Preferred stock, par $0.0007, 10,000,000 shares authorized, 2,500,000 shares issued and outstanding | 1,750 | 1,750 |
Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 shares issued and outstanding at December 31, 2017 and 2016 | 62,852,585 | 62,852,585 |
Additional paid-in capital | (37,566,509) | (37,566,509) |
Accumulated deficit | (26,188,082) | (26,120,406) |
Total deficiency in stockholders' equity | (900,256) | (832,580) |
Total Liabilities and Deficiency in Stockholders' Equity | $ 3,592 | $ 3,000 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2017 | Dec. 31, 2016 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value | $ 0.0007 | $ 0.0007 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 2,500,000 | 2,500,000 |
Preferred stock, shares outstanding | 2,500,000 | 2,500,000 |
Common stock, par value | $ 0.0007 | $ 0.0007 |
Common stock, shares authorized | 110,000,000,000 | 110,000,000,000 |
Common stock, shares issued | 89,789,407,996 | 89,789,407,996 |
Common stock, shares outstanding | 89,789,407,996 | 89,789,407,996 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
OPERATING EXPENSES: | ||
General and administrative expenses | $ 36,083 | $ 92,974 |
Professional fees | 31,593 | 44,588 |
Total expenses | 67,676 | 137,562 |
Loss from operations | (67,676) | (137,562) |
Other income and expense | ||
Loss on impairment | 113,774 | |
Write off of investment deposit | 20,000 | |
Interest income | (13) | |
Total other income and expense | 133,761 | |
Net loss before income taxes | (67,676) | (271,323) |
Income taxes | ||
Net loss | $ (67,676) | $ (271,323) |
Loss per weighted average common share | $ 0 | $ 0 |
Number of weighted average common shares outstanding - Basic and Diluted | 89,789,407,996 | 89,789,407,996 |
Consolidated Statement of Chang
Consolidated Statement of Changes in Deficiency in Stockholders Equity - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total |
Balance at Dec. 31, 2015 | $ 1,750 | $ 62,852,585 | $ (37,566,509) | $ (25,849,083) | $ (561,257) |
Balance, shares at Dec. 31, 2015 | 2,500,000 | 89,789,407,996 | |||
Net loss | (271,323) | (271,323) | |||
Balance at Dec. 31, 2016 | $ 1,750 | $ 62,852,585 | (37,566,509) | (26,120,406) | (832,580) |
Balance, shares at Dec. 31, 2016 | 2,500,000 | 89,789,407,996 | |||
Net loss | (67,676) | (67,676) | |||
Balance at Dec. 31, 2017 | $ 1,750 | $ 62,852,585 | $ (37,566,509) | $ (26,188,082) | $ (900,256) |
Balance, shares at Dec. 31, 2017 | 2,500,000 | 89,789,407,996 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (67,676) | $ (271,323) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Loss on impairment | 113,774 | |
Write off of investment deposit | 20,000 | |
Amortization of prepaid expense | 3,000 | |
Changes in operating assets and liabilities | ||
Increase in prepaid expense | (3,000) | (3,000) |
Increase in receivable from third party | (592) | |
Increase (decrease) in accounts payable and accrued liabilities | (741) | 21,110 |
Net cash used in operating activities | (69,009) | (119,439) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Deposit on purchase of software | (20,000) | |
Net cash used in investing activities | (20,000) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Repayments of related party advances | (17,141) | |
Proceeds from related party advances | 86,150 | 135,385 |
Net cash provided by financing activities | 69,009 | 135,385 |
Net change in cash | (4,054) | |
CASH, beginning of year | 4,054 | |
CASH, end of year | ||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Interest paid in cash | ||
Income tax paid in cash |
Nature of Operations
Nature of Operations | 12 Months Ended |
Dec. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations | (1) NATURE OF OPERATIONS World Health Energy Holdings, Inc., (the “Company,” or “WHEN”), was formed on May 21, 1986, under the laws of the State of Delaware and is based in Boca Raton, Florida. The Company has invested in a variety of software programs that it strove to commercialize, and has a subsidiary in clean energy technology which currently is dormant due to lack of funding. It is currently seeking software in the cyber-security arena to commercialize. |
Basis of Presentation and Use o
Basis of Presentation and Use of Estimates | 12 Months Ended |
Dec. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Use of Estimates | (2) BASIS OF PRESENTATION AND USE OF ESTIMATES a) Basis of Presentation The comparative amounts presented in these consolidated financial statements are the historical results of World Health Energy Holdings, Inc., inclusive of its wholly owned subsidiaries World Health Energy, Inc. (“WHEH”) and FSC Solutions, Inc. (“FSC”). All intercompany balances and transactions have been eliminated in consolidation b) Reclassifications Certain items in the 2016 financial statements have been reclassified to be comparable to the 2017 financial statements. c ) Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements involved the valuation of construction in progress, depreciable life of the floating vessel, valuation of long lived assets, debt discounts, valuation of common stock issued as compensation and valuation allowance of deferred income tax assets. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | (3) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a) Cash and cash equivalents The Company considers all highly liquid securities with original maturities of three months or less when acquired, to be cash equivalents. We had no financial instruments that qualified as cash equivalents at December 31, 2017 or 2016. b) Related Party Transactions All transactions with related parties are in the normal course of operations and are measured at the exchange amount. c) Financial instruments and Fair value measurements ASC 825-10 Financial Instruments, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. ASC 825 also requires disclosures of the fair value of financial instruments. The carrying value of the Company’s current financial instruments, which include cash and cash equivalents, accounts payable and accrued liabilities approximates their fair values because of the short-term maturities of these instruments. FASB ASC 820 Fair Value Measurement clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability. Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement. d) Income Taxes The Company uses the asset and liability method of ASC 740 to account for income taxes. Under this method, deferred income taxes are determined based on the differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements which will result in taxable or deductible amounts in future years and are measured using the currently enacted tax rates and laws. A valuation allowance is provided to reduce net deferred tax assets to the amount that, based on available evidence, is more likely than not to be realized. The Company follows the provisions of ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. As of December 31, 2017, the tax years 2017, 2016 and 2015 for the Company remain open for IRS audit. The Company has received no notice of audit or any notifications from the IRS for any of the open tax years. e) Net income (loss) per share Basic loss per share excludes dilution and is computed by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings of the Company. Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless consideration of such dilutive potential shares would result in anti-dilution. There were no common stock equivalents for the years ended December 31, 2017 or 2016. f) Recent accounting pronouncements In February 2016, the FASB issued ASU 2016-02, Leases which, for operating leases, requires a lessee to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight-line basis. The ASU is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company believes that the adoption of ASU 2016-02 will have no effect on the Company’s consolidated financial statements. |
Liquidity and Going Concern Con
Liquidity and Going Concern Considerations | 12 Months Ended |
Dec. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Liquidity and Going Concern Considerations | (4) LIQUIDITY AND GOING CONCERN CONSIDERATIONS Our consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company sustained a net loss of approximately $67,000 for the year ended December 31, 2017 and has an accumulated deficit of approximately $900,000 and a negative working capital of approximately $900,000 at December 31, 2017. These conditions raise substantial doubt about our ability to continue as a going concern. Failure to successfully develop operations and revenues could harm our profitability and materially adversely affect our financial condition and results of operations. We face all of the risks inherent in a new business, including the need for significant additional capital, management’s potential underestimation of initial and ongoing costs, and potential delays and other problems in connection with establishing our planned operations. We are continuing our plan to further grow and expand restaurant operations and seek sources of capital to pay our contractual obligations as they come due. Management believes that its current operating strategy will provide the opportunity for us to continue as a going concern as long as we are able to obtain additional financing; however, there is no assurance this will occur. The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern. The independent auditors’ report on our consolidated financial statements for the years ended December 31, 2017 contained an explanatory paragraph expressing substantial doubt as to our ability to continue as a going concern. |
Receivable from Third Party
Receivable from Third Party | 12 Months Ended |
Dec. 31, 2017 | |
Receivables [Abstract] | |
Receivable from Third Party | (5) RECEIVABLE FROM THIRD PARTY The Company advanced funds to a third party with no stated maturity or interest rate with a balance of $592 at December 31, 2017. |
Due to Related Parties
Due to Related Parties | 12 Months Ended |
Dec. 31, 2017 | |
Related Party Transactions [Abstract] | |
Due to Related Parties | (6) DUE TO RELATED PARTIES Certain stockholders and officers paid expenses of the Company and were reimbursed finds during the year. The net amount due to related parties was $794,076 and $725,067 December 31, 2017 and 2016, respectively. |
Related Party Convertible Note
Related Party Convertible Note Payable | 12 Months Ended |
Dec. 31, 2017 | |
Related Party Convertible Note Payable | |
Related Party Convertible Note Payable | (7) RELATED PARTY CONVERTIBLE NOTE PAYABLE During 2014, the Company entered into a convertible note payable with a third party for $21,474. The note is non-interest bearing and is convertible to common stock at $0.0001 per share (or the comparable rate following any share split or reverse split) on the conversion date. During 2015 the note holder became the CEO and became a related party. |
Stockholders' Deficit
Stockholders' Deficit | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Stockholders' Deficit | (8) STOCKHOLDERS’ DEFICIT At December 31, 2017 and 2016, the Company has 110,000,000,000 shares of par value $0.0007 common stock authorized and 89,789,407,996 shares issued and outstanding. At December 31, 2017 and 2016, the Company has 10,000,000 shares of par value $0.0007 preferred stock and 2,500,000 shares issued and outstanding. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | (9) - INCOME TAXES The Company’s effective income tax expense (benefit) differs from the expected tax expense for Federal income tax purposes, (computed by applying the United States Federal tax rate of 34% to loss before taxes) as follows: 2017 2016 Tax (benefit) on net loss before income tax $ (10,197 ) $ (82,401 ) Effect of state taxes (net of federal benefit) (2,835 ) (14,923 ) Increase in valuation allowance 13,032 97,324 Income tax provision $ - $ - The Company recognizes deferred tax assets and liabilities for the tax effects of differences between the financial statements and tax basis of assets and liabilities. The components of net deferred tax assets and liabilities that have been presented in the Company’s financial statements are as follows at December 31, 2017: Deferred income tax assets: 2017 2016 Net operating loss carryforward $ 9,382,422 $ 9,272,066 Total deferred tax assets 9,382,422 9,272,066 Valuation allowance (9,382,422 ) (9,272,066 ) Net deferred taxes $ - $ - The Company records a valuation allowance to reduce deferred tax assets, based on the weight of the available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. In determining the need for a valuation allowance, an assessment of all available evidence both positive and negative was required. The Company recorded a valuation allowance of $13,032 in 2017 and $97,324 in 2016. We have recorded a 100% valuation allowance related to the deferred tax asset for the loss from operations. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which temporary differences become deductible. In accordance with the provisions of ASC 740: Income Taxes, we record a liability for uncertain tax positions when it is probable that a loss has been incurred and the amount can be reasonably estimated. At December 31, 2017 and 2016, we have no liabilities for uncertain tax positions. We continually evaluate expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative rulings. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | (10) COMMITMENTS AND CONTINGENCIES a) Legal Matters From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of December 31, 2017, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2017 | |
Subsequent Events [Abstract] | |
Subsequent Events | (11) SUBSEQUENT EVENTS a) Due to related parties In 2018, one related party died and the other resigned. The related party that resigned and the estate of the deceased related party entered into settlement agreements with the Company on the amounts due them by the Company. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Cash and Cash Equivalents | a) Cash and cash equivalents The Company considers all highly liquid securities with original maturities of three months or less when acquired, to be cash equivalents. We had no financial instruments that qualified as cash equivalents at December 31, 2017 or 2016. |
Related Party Transactions | b) Related Party Transactions All transactions with related parties are in the normal course of operations and are measured at the exchange amount. |
Financial Instruments and Fair Value Measurements | c) Financial instruments and Fair value measurements ASC 825-10 Financial Instruments, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. ASC 825 also requires disclosures of the fair value of financial instruments. The carrying value of the Company’s current financial instruments, which include cash and cash equivalents, accounts payable and accrued liabilities approximates their fair values because of the short-term maturities of these instruments. FASB ASC 820 Fair Value Measurement clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability. Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement. |
Income Taxes | d) Income Taxes The Company uses the asset and liability method of ASC 740 to account for income taxes. Under this method, deferred income taxes are determined based on the differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements which will result in taxable or deductible amounts in future years and are measured using the currently enacted tax rates and laws. A valuation allowance is provided to reduce net deferred tax assets to the amount that, based on available evidence, is more likely than not to be realized. The Company follows the provisions of ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. As of December 31, 2017, the tax years 2017, 2016 and 2015 for the Company remain open for IRS audit. The Company has received no notice of audit or any notifications from the IRS for any of the open tax years. |
Net Income (loss) Per Share | e) Net income (loss) per share Basic loss per share excludes dilution and is computed by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings of the Company. Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless consideration of such dilutive potential shares would result in anti-dilution. There were no common stock equivalents for the years ended December 31, 2017 or 2016. |
Recent Accounting Pronouncements | f) Recent accounting pronouncements In February 2016, the FASB issued ASU 2016-02, Leases which, for operating leases, requires a lessee to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight-line basis. The ASU is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company believes that the adoption of ASU 2016-02 will have no effect on the Company’s consolidated financial statements. |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Expense (Benefit) | The Company’s effective income tax expense (benefit) differs from the expected tax expense for Federal income tax purposes, (computed by applying the United States Federal tax rate of 34% to loss before taxes) as follows: 2017 2016 Tax (benefit) on net loss before income tax $ (10,197 ) $ (82,401 ) Effect of state taxes (net of federal benefit) (2,835 ) (14,923 ) Increase in valuation allowance 13,032 97,324 Income tax provision $ - $ - |
Schedule of Deferred Tax Assets and Liabilities | The components of net deferred tax assets and liabilities that have been presented in the Company’s financial statements are as follows at December 31, 2017: Deferred income tax assets: 2017 2016 Net operating loss carryforward $ 9,382,422 $ 9,272,066 Total deferred tax assets 9,382,422 9,272,066 Valuation allowance (9,382,422 ) (9,272,066 ) Net deferred taxes $ - $ - |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details Narrative) | 12 Months Ended |
Dec. 31, 2017shares | |
Accounting Policies [Abstract] | |
Income tax likeliehood description | More than 50 percent |
Antidilutive securities excluded from computation of earnings per share |
Liquidity and Going Concern C_2
Liquidity and Going Concern Considerations (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Net loss | $ (67,676) | $ (271,323) |
Accumulated deficit | (26,188,082) | $ (26,120,406) |
Negative working capital | $ 900,000 |
Receivable from Third Party (De
Receivable from Third Party (Details Narrative) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Receivables [Abstract] | ||
Receivable from third party | $ 592 |
Due to Related Parties (Details
Due to Related Parties (Details Narrative) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Related Party Transactions [Abstract] | ||
Amount due to related parties | $ 794,076 | $ 725,067 |
Related Party Convertible Not_2
Related Party Convertible Note Payable (Details Narrative) - Third Party [Member] | Dec. 31, 2014USD ($)$ / shares |
Convertible note payable | $ | $ 21,474 |
Debt instrument conversion price per shares | $ / shares | $ 0.0001 |
Stockholders' Deficit (Details
Stockholders' Deficit (Details Narrative) - $ / shares | Dec. 31, 2017 | Dec. 31, 2016 |
Equity [Abstract] | ||
Common stock, shares authorized | 110,000,000,000 | 110,000,000,000 |
Common stock, par value | $ 0.0007 | $ 0.0007 |
Common stock, shares issued | 89,789,407,996 | 89,789,407,996 |
Common stock, shares outstanding | 89,789,407,996 | 89,789,407,996 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, par value | $ 0.0007 | $ 0.0007 |
Preferred stock, shares issued | 2,500,000 | 2,500,000 |
Preferred stock, shares outstanding | 2,500,000 | 2,500,000 |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Income Tax Disclosure [Abstract] | ||
Federal tax rate | 34.00% | |
Valuation allowance | $ 13,032 | $ 97,324 |
Valuation allowance related to the deferred tax asset | 100.00% | |
Liabilities for uncertain tax positions |
Income Taxes - Schedule of Effe
Income Taxes - Schedule of Effective Income Tax Expense (Benefit) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Income Tax Disclosure [Abstract] | ||
Tax (benefit) on net loss before income tax | $ (10,197) | $ (82,401) |
Effect of state taxes (net of federal benefit) | (2,835) | (14,923) |
Increase in valuation allowance | 13,032 | 97,324 |
Income tax provision |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) | Dec. 31, 2017 | Dec. 31, 2016 |
Income Tax Disclosure [Abstract] | ||
Net operating loss carryforward | $ 9,382,422 | $ 9,272,066 |
Total deferred tax assets | 9,382,422 | 9,272,066 |
Valuation allowance | (9,382,422) | (9,272,066) |
Net deferred taxes |